jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

April. 05, 2021

Nov. 01, 2021

jRCT2031210011

A phase II study to evaluate the efficacy and safety of M605106 short contact therapy in patients with acne vulgaris

A phase II study of M605106 for acne vulgaris

Nishiura Tomoyuki

Maruho Co.,Ltd. Kyoto R&D Center

93 chudoji Awatacho, Shimogyo-ku, Kyoto

+81-75-325-3279

ctinfo@mii.maruho.co.jp

- Clinical Trials Infomation

Maruho Co.,Ltd. Kyoto R&D Center

93 chudoji Awatacho, Shimogyo-ku, Kyoto

+81-75-325-3279

ctinfo@mii.maruho.co.jp

Not Recruiting

April. 05, 2021

April. 01, 2021
240

Interventional

randomized controlled trial

double blind

placebo control

parallel assignment

treatment purpose

Patients with Acne vulgaris 12 to 49 years old

- Patients with concurrent presense of serious cardiac, hepatic, renal, plumonary, hematologic, or other diseases considered inappropriate for paticipation in the clinical study
- Patients with a history of hypersensitivity to investigational drug ingredients
- Pregnant or lactating women

12age old over
49age old under

Both

Acne vulgaris

Apply an appropriate amount once a day and remove after a short time.

Percentage change in total lesion count after a certain period

Maruho Co.,Ltd.
Doujin Memorial Medical Foundation, Meiwa Hospital IRB
1-18,Kandasudacho,Chiyodaku, Tokyo

+81-3-5543-0196

jimukyoku@smo-msr.co.jp
Approval

No

none

History of Changes

No Publication date
2 Nov. 01, 2021 (this page) Changes
1 April. 05, 2021 Detail